This study aims to develop and validate a predictive nomogram for severe postoperative pleural effusion (SPOPE) in patients undergoing hepatectomy for liver cancer. A total of 536 liver cancer patients who underwent hepatectomy at the Department of Hepatobiliary Surgery I of the Affiliated Hospital of North Sichuan Medical College from January 1, 2018, to December 31, 2022, were enrolled in a retrospective observational study and comprised the training dataset. Lasso regression and logistic regression analyses were employed to construct a predictive nomogram. The nomogram was internally validated using Bootstrapping and externally validated with a dataset of 203 patients who underwent liver cancer resection at the Department of General Surgery III of the same hospital from January 1, 2020, to December 31, 2022. We evaluated the nomogram using the receiver operating characteristic curve, calibration curve, and decision curve analysis. Variables such as drinking history, postoperative serum albumin, postoperative total bilirubin, right hepatectomy, diaphragm incision, and intraoperative blood loss were observed to be associated with SPOPE. These factors were integrated into our nomogram. The C-index of the nomogram was 0.736 (95% CI: 0.692–0.781) in the training set and 0.916 (95% CI: 0.872–0.961) in the validation set. The nomogram was then evaluated using sensitivity, specificity, positive predictive value, negative predictive value, calibration curve, and decision curve analysis. The nomogram demonstrates good discriminative ability, calibration, and clinical utility.
Rationale: Cystic duct (CD) variations are common biliary tract alterations; therefore, caution is required in the diagnosis and treatment of cholelithiasis in patients with gallbladder duct anomalies. Laparoscopic cholecystectomy (LC) is the preferred method for treating cholelithiasis or cholecystitis. Accurate preoperative imaging assessment, a thorough understanding of relevant surgical anatomy, and intraoperative precautions are required to effectively reduce the incidence of intraoperative bile duct injury. Patient concerns: We report the case of a 59-year-old male patient with common hepatic duct (CHD) stricture following LC. The patient’s CD entered the common bile duct from the left side and ran ventrally around the common bile duct. Postoperative examination revealed partial stenosis of the CHD caused by compression from an absorbable ligation clip and transient hyperbilirubinemia. Fortunately, prompt treatment prevented serious complications. Diagnoses: Cholelithiasis with cholecystitis and CD anatomical variation. Interventions: LC. Outcomes: Postoperative examination revealed partial stenosis of the CHD caused by compression from an absorbable ligation clip, with transient hyperbilirubinemia. The patient was discharged 3 days postoperatively and followed up for 10 months. The absorbable ligation clips were resorbed, and the CHD stenosis resolved. Lessons: Biliary tract surgeons must understand and master common variations of the CD and their clinical significance. Potential anatomical variations should be identified preoperatively, while the extrahepatic bile ducts should be carefully exposed intraoperatively. Whenever possible, absorbable ligation clips should be used to transect the CD while avoiding compression of the bile duct to prevent bile duct injury.
Objective: 3’-Phosphoadenosine 5’-phosphosulfate (PAPS) synthase 2 (PAPSS2) catalyzes the rate-limiting step in sulfation metabolism by generating the universal sulfate donor PAPS. However, its biological and clinical significance in gastric cancer (GC) remains poorly understood. Methods: We analyzed PAPSS2 expression, prognostic value, immune infiltration correlates, promoter methylation, and histone acetylation patterns using public databases. Expression levels were validated by qRT-PCR and western blotting. Functional assays —CCK-8, Transwell migration/invasion, and HUVEC tube formation assays— assessed the oncogenic roles of PAPSS2. Finally, we performed ChIP assay to investigate the epigenetic mechanism driving PAPSS2 upregulation in GC. Results: PAPSS2 was significantly upregulated in GC tissues and cell lines, and high PAPSS2 expression correlated with poorer patient survival. Co-expression network analysis linked PAPSS2-associated genes to extracellular matrix organization, angiogenesis, and metastatic progression. Functional knockdown of PAPSS2 suppressed GC cell proliferation, migration, and invasion; impaired VEGFA-driven angiogenesis; and inhibited M2 macrophage polarization. Mechanistically, promoter hypomethylation and p300/CBP-mediated H3K27 acetylation may contribute to PAPSS2 overexpression in GC cells. Conclusion: Epigenetically driven PAPSS2 overexpression promotes GC cell proliferation and migration, potentiates VEGFA-dependent angiogenesis, and facilitates M2 macrophage polarization, highlighting PAPSS2 as a potential therapeutic target in GC.